Package 80425-0195-3

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 80425-0195-3
Digits Only 8042501953
Product NDC 80425-0195
Description

90 TABLET in 1 BOTTLE (80425-0195-3)

Marketing

Marketing Status
Marketed Since 2024-02-25
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2a9a0577-70c7-0284-e063-6394a90ae582", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226"], "spl_set_id": ["d8dff98f-185e-77ba-e053-2995a90aed2f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Advanced Rx Pharmacy of Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (80425-0195-2)", "package_ndc": "80425-0195-2", "marketing_start_date": "20240225"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (80425-0195-3)", "package_ndc": "80425-0195-3", "marketing_start_date": "20240225"}], "brand_name": "Topiramate", "product_id": "80425-0195_2a9a0577-70c7-0284-e063-6394a90ae582", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "80425-0195", "generic_name": "Topiramate", "labeler_name": "Advanced Rx Pharmacy of Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20220614", "listing_expiration_date": "20261231"}